Welcome to LookChem.com Sign In|Join Free

CAS

  • or

160351-97-3

Post Buying Request

160351-97-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

160351-97-3 Usage

General Description

Cyclobutanecarboxylic acid, 3-hydroxy-, ethyl ester, cis- (9CI) is a chemical compound with a molecular weight of 172.21 g/mol. It falls under the category of cyclobutanes and is used in the field of organic synthesis. The cis- isomer in the compound refers to molecular geometry where functional groups are on the same side of the cyclobutane ring. Its applications in the porous materials, pharmaceutical manufacturing, and chemical research fields capture its major use. The Ethyl ester functional group in the compound makes it more reactive.

Check Digit Verification of cas no

The CAS Registry Mumber 160351-97-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,0,3,5 and 1 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 160351-97:
(8*1)+(7*6)+(6*0)+(5*3)+(4*5)+(3*1)+(2*9)+(1*7)=113
113 % 10 = 3
So 160351-97-3 is a valid CAS Registry Number.
InChI:InChI=1/C7H12O3/c1-2-10-7(9)5-3-6(8)4-5/h5-6,8H,2-4H2,1H3/t5-,6+

160351-97-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name (1s,3s)-ethyl 3-hydroxycyclobutanecarboxylate

1.2 Other means of identification

Product number -
Other names Cyclobutanecarboxylic acid, 3-hydroxy-, ethyl ester, cis-

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:160351-97-3 SDS

160351-97-3Relevant articles and documents

ISOXAZOLE DERIVATIVES FOR USE IN THE TREATMENT OF PULMONARY DISEASES AND DISORDERS

-

Paragraph 0189, (2017/03/21)

The present disclosure features disclosed method of treating disorders such as COPD, bronchitis and/or asthma using disclosed compounds, optionally together with one or more additional active agents. Contemplated methods include administrating orally or by inhalation to a patient one or more disclosed compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 160351-97-3